Biofrontera Inc. Increase (Decrease) in Other Current Assets
Biofrontera Inc. (BFRI) reported Increase (Decrease) in Other Current Assets of -$452.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-13
- Biofrontera Inc. increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$427.00K.
- Biofrontera Inc. increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$25.00K.
- Biofrontera Inc. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$47.00K.
- Biofrontera Inc. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$220.00K.
- Biofrontera Inc. increase (decrease) in other current assets for fiscal 2025 was $686.00K.
- Biofrontera Inc. increase (decrease) in other current assets for fiscal 2024 was -$5.16M, a 200.00% decline from fiscal 2023.
- Biofrontera Inc. increase (decrease) in other current assets for fiscal 2023 was $5.16M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$427.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$452.00K 10-Q · filed 2026-08-13 | -$499.00K derived: sum of 3 quarters · filed 2026-08-13 | -$719.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$25.00K 10-Q · filed 2026-05-14 | -$72.00K derived: sum of 2 quarters · filed 2026-05-14 | -$292.00K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$267.00K derived: sum of 2 quarters · filed 2026-03-19 | $686.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | -$220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $733.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $953.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$5.16M 10-K · filed 2026-03-19 | ||
| 2024-09-30 | -$5.16M 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | $5.16M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |